Treating Alzheimer’s patients with TPS: More and more neurologists add TPS to their range of therapies

Transcranial Pulse Stimulation (TPS®) with the NEUROLITH® is increasingly gaining momentum: Since the CE approval for the »treatment of the central nervous system of patients with Alzheimer’s disease« in 2018, more than 50 NEUROLITH® systems have been installed worldwide. In June 2021, three more devices were installed in renowned neurological specialist clinics in Germany, Austria, and Turkey.

»My father seems to be more present now. In the first test he didn't know the day of the week, in the retest he did. I also have the impression that his voice is somewhat stronger and that he can now give more emphasis to his statements.« O.W., relative of an Alzheimer’s patient, on treatment with TPS® in the practice of Dr Spiecker (Achern, Germany).